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Cellular infection by cytomegalovirus (CMV) is associated with very early G-protein-mediated signal trans-
duction and reprogramming of gene expression. Here we investigated the involvement of human CMV
(HCMV)-encoded US27, US28, and UL33 receptors as well as murine CMV-encoded M33 transmembrane
(7TM) receptors in host cell signaling mechanisms. HCMV-encoded US27 did not show any constitutive
activity in any of the studied signaling pathways; in contrast, US28 and M33 displayed ligand-independent,
constitutive signaling through the G protein q (Gq)/phospholipase C pathway. In addition, M33 and US28 also
activated the transcription factor NF-B as well as the cyclic AMP response element binding protein (CREB)
in a ligand-independent, constitutive manner. The use of specific inhibitors indicated that the p38 mitogen-
activated protein (MAP) kinase but not the extracellular signal-regulated kinase 1/2–MAP kinase pathway is
involved in M33- and US28-mediated CREB activation but not NF-B activation. Interestingly, UL33—the
HCMV-encoded structural homologue of M33—was only marginally constitutively active in the Gq/phospho-
lipase C turnover and CREB activation assays and did not show any constitutive activity in the NF-B pathway,
where M33 and US28 were highly active. Hence, CMVs appear to have conserved mechanisms for regulating
host gene transcription, i.e., constitutive activation of certain kinases and transcription factors through the
constitutive activities of 7TM proteins. These data, together with the previous identification of the incorpora-
tion of such proteins in the viral envelope, suggest that these proteins could be involved in the very early
reprogramming of the host cell during viral infection.
Cytomegaloviruses (CMVs) are widespread opportunistic
pathogens that cause acute, latent, and chronic infections. Al-
though the primary infection is asymptomatic in immunocom-
petent individuals, these viruses can cause a wide variety of
diseases in immunocompromised hosts (2). One hallmark of
human CMV (HCMV) infection of quiescent cells is the up-
regulation of many host cell proteins, including DNA replica-
tion enzymes and transcription factors, which are necessary for
both viral gene expression and viral DNA replication. Inter-
estingly, some of these cellular changes occur even before the
activation of the immediate-early genes of the virus, and some
of these changes are clearly associated with classical G-protein
signaling pathways. For example, the exposure of human fibro-
blasts to HCMV is associated with a very rapid G-protein-
dependent increase in phospholipase C (PLC) activity, as re-
flected in the intracellular levels of diacylglycerol and inositol
1,4,5-triphosphate, as well as the rapid release of arachidonic
acid metabolites (1).
HCMV encodes four putative 7-transmembrane (7TM) G-
protein-coupled receptors, US27 and US28 (both HCMV spe-
cific) and UL33 and UL78 (both betaherpesvirus conserved)
(11, 20, 31) (Fig. 1), with structural homology to chemokine
receptors. So far, only US28 has been characterized pharma-
cologically and shown to bind several CC chemokines, such as
MIP-1/CCL3, MCP-1/CCL2, MIP-1/CCL4, and RANTES/
CCL5 (31), as well as the CX3C chemokine fractalkine/
CX3CL1, with a high affinity (26). Of these, RANTES/CCL5
and MCP-1/CCL2 were able to mediate the migration of
smooth muscle cells following CMV infection, suggesting that
US28 is one of the possible causative agents in the pathogen-
esis of artherosclerosis and restenosis (39). While mostly in-
tracellular, US28 has also been suggested to enhance cell-cell
fusion, demonstrating its potential importance in the cell-to-
cell spread of HCMV in vivo (23, 26). The betaherpesvirus
family members UL33 and UL78 (Fig. 1) have been less well
characterized; while ligand(s) for UL33 have not yet been
identified, the critical importance of the rodent CMV counter-
parts, M33 and R33 (Fig. 1, right bottom cluster), has been
demonstrated through in vivo analysis of gene-knockout vi-
ruses. Viruses with M33 and R33 deleted were less virulent and
were unable to disseminate to or replicate within the salivary
glands. The salivary glands are the major site for CMV persis-
tence and transmission; thus, M33 and R33 appear to play
critical roles in this aspect of the virus life cycle (5, 13). For
both animal viruses, only one more putative 7TM product has
been described, M78 (32) and R78 (4), respectively (Fig. 1, top
cluster).
Initial studies on the signal transduction properties of US28
revealed that this receptor accounts for calcium mobilization in
response to high CC chemokine concentrations in HCMV-
infected cells (41) as well as for RANTES/CCL5-mediated
extracellular signal-regulated kinase (ERK)–mitogen-activated
protein (MAP) kinase activation in specialized cellular envi-
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ronments (6). Recently, US28 was shown to regulate the G
protein q (Gq)/PLC pathway in a ligand-independent, consti-
tutively active manner and to upregulate the transcription fac-
tor NF-B (10).
Here we studied the constitutive activation of the Gq/PLC/
inositol pathway and the upregulation of transcription factors
by the murine CMV (MCMV) M33 and HCMV US27, US28,
and UL33 chemokine receptor-like proteins. Moreover, we
extended the search for potential downstream effectors of
these viral 7TM proteins and found that the cyclic AMP
(cAMP) response element binding protein (CREB) is consti-
tutively upregulated via some of these proteins. Since both
NF-B and CREB are regulated by the concerted action of
various host cell kinases—many of which are known to be
upregulated in early CMV infectious processes—we investi-
gated the potential involvement of p38 MAP kinase and
ERK1/2-MAP kinase in regulating the respective transcription
factors.
MATERIALS AND METHODS
Chemokines and receptor constructs. CX3CL1 (i.e., the chemokine domain
corresponding to amino acids 1 through 69 of fractalkine) and RANTES/CCL5
were purchased from R&D Systems. MCP-3/CCL7 and MIP-1/CCL4 were
purchased from Peprotech (Rocky Hill, N.J.). MIP-1/CCL3, MCP-1/CCL2,
vMIP-II/vCCL2, and the cDNA encoding the US28 chemokine receptor (AD169
strain of HCMV) were kindly provided by Timothy N. C.Wells (Serono Phar-
macological Research Institute, Geneva, Switzerland). M33 (long-splice variant)
was cloned from mouse embryonic fibroblasts infected with the K181 strain of
MCMV, UL33 (long-splice variant) was cloned from a human foreskin fibroblast
culture infected with the AD169 strain of HCMV (13), and US27 was cloned
from fibroblast cultures infected with the AD169 strain of HCMV (kindly pro-
vided by Allan Hornsleth, University of Copenhagen) by using PCR. For mi-
croscopy studies, US28, UL33, and M33 were fused upstream of and in frame
with enhanced green fluorescence protein (EGFP), and US27 was tagged with
yellow fluorescence protein (YFP). All constructs were cloned in the eukaryotic
expression vector pTEJ8 (24) and verified by DNA sequencing. Pertussis toxin
(PTX) was purchased from Sigma. PD98059 and SB202190 were obtained from
Calbiochem.
Transfections and cells. COS-7 cells were grown with 10% CO2 at 37°C in
Dulbecco’s modified Eagle’s medium 1885 supplemented with 10% fetal calf
serum, 2 mM glutamine, and 100 U of penicillin G-streptomycin/ml. Cells were
transiently transfected with cDNA by using the calcium phosphate precipitation
method (12) or with Lipofectamine 2000 (Life Technologies)
Phosphatidylinositol assay. COS-7 cells were transferred to 12-well culture
plates 1 day after transfection. Cells (2.5 105 cells/well) were incubated for 24 h
with 5Ci of myo-[3H]inositol in 0.5 ml of complete medium/well. Cells were
washed twice in 20 mM HEPES buffer (pH 7.4) supplemented with 140 mM
NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 10 mM glucose, and 0.05%
(wt/vol) bovine serum albumin and were incubated in 0.5 ml of buffer supple-
mented with 10 mM LiCl at 37°C for 45 min in the presence of various concen-
trations of chemokines. Cells were extracted by the addition of 0.5 ml of 10%
ice-cold perchloric acid; this step was followed by incubation on ice for 30 min.
The cell extracts were neutralized with KOH in HEPES buffer, and the gener-
ated [3H]inositol phosphates were purified on AG 1X8 anion-exchange resin.
Reporter gene assays. COS-7 cells (35,000 cells/well) seeded in 96-well plates
were transiently transfected with a reporter-cDNA cocktail consisting of pFA2-
CREB and pFR-Luc reporter plasmids (PathDetect CREB trans-Reporting sys-
tem; Stratagene) or pNF-B-Luc (PathDetect cis-Reporting system; Stratagene)
and various amounts of receptor DNA. Following transfection, cells were treated
with the respective compounds in an assay volume of 100 l for 24 h. When
treated with chemokines, cells were maintained with a low serum concentration
(2.5%) throughout the experiments. The assay was terminated by washing the
cells twice with phosphate-buffered saline and adding 100 l of luciferase assay
reagent (LucLite; Packard). Luminescence was measured in a TopCounter (Top
Count NXT; Packard) for 5 s. Luminescence values are given as relative light
units (RLU).
Fluorescence microscopy. COS-7 cells expressing the green fluorescence pro-
tein (GFP)-labeled receptor constructs 2 days after transfection were used for
fluorescence microscopy. At 24 h posttransfection, cells were plated on coverslips
and allowed to grow for 24 h. Subsequently, cells were fixed with 3.7% formal-
dehyde in phosphate-buffered saline for 20 min at room temperature and
mounted in Vectashield mounting medium (Vector Laboratories). Cells were
analyzed by using an inverse Zeiss Axiovert 200 fluorescence microscope
equipped with a Coolsnap charge-coupled device camera. Digital images were
transferred to Adobe Photoshop and used without further processing.
RESULTS AND DISCUSSION
Effect of receptor expression on phosphatidylinositol turn-
over. A classical way of studying constitutive signaling of re-
ceptors is to perform gene dose experiments, where cells are
transfected with increasing amounts of a plasmid coding for
the receptor and the relevant second messenger is measured in
the cells in the absence of an added receptor ligand (3, 34).
Figure 2 shows that of the four tested CMV proteins expressed
in COS-7 cells, only US28 induced a clear increase in phos-
phatidylinositol turnover in a gene-dose-dependent manner
above the control. M33 and UL33 each showed a marginal
degree of constitutive activity, whereas US27 did not display
any constitutive activity above the baseline (pTEJ8). This lack
of signaling cannot be accounted for by a failure of receptor
expression, as this was verified by fluorescence detection of
GFP-tagged receptors (see below).
Cellular localization. It was previously demonstrated that
although US28 is expressed at the cell surface, it is constitu-
tively internalized, and the majority of these receptors accu-
FIG. 1. Dendrogram of CMV-encoded chemokine receptors based
on their amino acid identities. This phylogenetic tree was generated by
Francois Talabot, Serono Pharmacological Research Institute, by us-
ing Clustal W 1.5 alignments of the full amino acid sequences followed
by analysis with the Distance program (Genetics Computer Group,
Madison, Wis.). The length of each branch reflects the identity be-
tween the receptors. Tree View (http://taxonomy.zoology.gla.ac.uk/rod
/rod.html) was used for graphic presentation. Asterisks indicate mem-
bers of the human CMV receptor family.
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mulate in late endosomes in the perinuclear region of the cell
(16). Figure 3 shows that US27-YFP is located in a pattern
rather similar to that of US28-EGFP (Fig. 3A and B), i.e.,
mostly in intracellular and perinuclear compartments. Al-
though UL33-EGFP is expressed slightly more on the cell
surface than US27 and US28, the majority of the protein is still
found inside the cell (Fig. 3C). In contrast, M33-EGFP is
located primarily on the cell surface, although a fraction is seen
within cells in the perinuclear region (Fig. 3D). HCMV virions
have been proposed to obtain their outer membrane from
endosomal compartments (40), and both UL33 and US27 have
been shown to be part of the viral envelope (29). By immuno-
labeling cryosections of HCMV-infected cells, it was recently
demonstrated that both US27 and UL33 are located in the
membranes of multivesicular endosomes and small membrane
vesicles, and HCMV virions could be seen budding into these
membranes (17). Since US27, US28, UL33, and potentially
M33 may be incorporated into virions and thereby delivered to
new cells during infection, these proteins may be involved in
the very rapid reprogramming of newly infected cells.
Activation of the nuclear transcription factor NF-B. Sev-
eral immediate-early and early viral promoters contain DNA
FIG. 2. Inositol phosphate (PI) accumulation induced by US27,
US28, UL33, and M33 receptor activities. Gene dose experiments with
increasing concentrations of US27 (white bar), US28 (black bar),
UL33 (grey bar), and M33 (hatched bar) receptor DNAs were per-
formed with transiently transfected COS-7 cells. One hundred percent
corresponds to the basal activity of cells transfected with 20 g of the
empty expression vector pTEJ8. Data are means and standard errors
of the means for three experiments carried out in quadruplicate.
FIG. 3. Cellular localization of US28, US27, UL33, and M33 in COS-7 cells. COS-7 cells were transiently transfected with US28-EGFP (A),
US27-YFP (B), UL33-EGFP (C), or M33-EGFP (D). US28-EGFP (A) and US27-YFP (B) were mostly located on intracellular vesicles in the
perinuclear regions of the cells. UL33-EGFP (C) was distributed both intracellulary and on the cell surface. M33-EGFP (D) was found
predominantly on the cell membrane surface. Shown are representative fluorescence microscopy images of the distribution of the GFP- and
YFP-tagged receptors taken with a 100 oil immersion objective. Bar, 10 m
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binding sites for a number of cellular transcription factors of
the host (30). These include CREB, NF-B, serum response
factor, and numerous cellular proto-oncogenes, such as c-myc,
c-jun, and c-fos, have been shown to be induced after HCMV
infection (8, 15, 42). This activation ensures high levels of
expression of many viral and cellular genes, which are required
for completion of the lytic viral life cycle. HCMV activates
NF-B-mediated transcription very rapidly after cellular infec-
tion, and one of the major targets that is transactivated by
NF-B is the major immediate-early gene promoter of HCMV
itself. Although it has long been proposed that NF-B activa-
tion by HCMV occurs through a G-protein-mediated mecha-
nism (9, 37, 38), to date only US28 out of the four HCMV-
encoded 7TM receptors has been described to constitutively
activate NF-B (Fig. 4A) (10). Here, we tested whether US27,
UL33, and its murine homologue M33 also could activate
NF-B. As shown in Fig. 4D, M33 was highly constitutively
active in the induction of NF-B. In contrast, neither UL33
(Fig. 4C) nor US27 (Fig. 4B) showed a significant gene-dose-
dependent activation of NF-B above that of the control trans-
fected cells.
Activation of the transcription factor CREB. CREB acti-
vates the transcription of target genes in response to a diverse
array of stimuli, including peptide hormones, growth factors,
and neuronal activity, that activate not only protein kinase A
(PKA) but also a variety of other kinases, such as MAP kinases
and Ca2/calmodulin-dependent protein kinases (for a review,
see reference 36). For HCMV, sustained MAP kinase activity
has been shown to be a major event in the very early infection
process, resulting in CREB-mediated induction of immediate-
early genes (33). While US27 (Fig. 5B) could not raise CREB
activity above the baseline, US28 (Fig. 5A) was able to activate
the CREB reporter in a ligand-independent manner. Interest-
ingly, in this experiment, UL33 (Fig. 5C) was capable of con-
stitutively regulating CREB-luciferase to a degree similar to
that seen with US28. The murine homologue of UL33, M33,
showed strong constitutive activation of CREB-luciferase (Fig.
5D).
Effect of chemokines on the constitutive activity of US28. A
direct demonstration of the degree of constitutive receptor
signaling in a given cellular setting requires the use of a suit-
able inverse agonist as a pharmacological tool, as previously
shown for the ORF-74 receptor from human herpesvirus 8
(34). However, US27, UL33, and M33 have not yet been “de-
orphanized” in terms of identification of their endogenous
ligands; thus, the following experiments were limited to US28,
which is known to be a broad-spectrum receptor for CC che-
mokines (18, 26, 27, 31). However, none of the CC chemokine
ligands tested (RANTES/CCL5, MIP-1/CCL3, MIP-1/
CCL4, MCP-1/CCL2, MCP-3/CCL7, and vMIP-II/vCCL2) af-
fected US28-mediated constitutive inositol phosphate turnover
(Fig. 6A) or NF-B or CREB transcription (data not shown).
As previously demonstrated, US28 was optimized to specifi-
cally recognize the membrane-associated CX3C chemokine,
fractalkine/CX3CL1, with a high affinity (26). The chemokine
domain of fractalkine/CX3CL1 (100 nM) acted as a partial
inverse agonist for US28, as it decreased signaling to approx-
imately 70% for inositol phosphate turnover (Fig. 6A and B).
An even more profound effect of fractalkine/CX3CL1 was ob-
served for US28-mediated CREB activation (Fig. 6C), whereas
FIG. 4. Gene-dose-dependent induction of NF-B activity by US28, US27, UL33, and M33. Induction of NF-B–luciferase was determined in
transiently transfected COS-7 cells (35,000 cells/well). Cells were cotransfected with 50 ng of NF-B–luciferase vector together with increasing
amounts of either pTEJ8 vector DNA (white bars) as a control or US28 (A), US27 (B), UL33 (C), or M33 (D) DNA (black bars). Shown are
representative results from at least four independent experiments performed in quadruplicate. Data are means and standard errors of the means.
RLU were measured with a Packard TopCounter (5 s/well).
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RANTES/CCL5 or any of the other above-mentioned chemo-
kines had no effect on constitutive CREB activation by US28
(Fig. 6B and C). The same chemokine profile was previously
reported for NF-B activation by US28 (10). In addition, no
ligand-induced inositol phosphate turnover could be observed
when COS-7 cells were transiently transfected with US27 (Fig.
6B).
p38 MAP kinase but not ERK1/2-MAP kinase is partially
involved in US28-, UL33-, and M33-mediated CREB activa-
tion. Since the transactivation function of many cellular tran-
scription factors is at least partially regulated by phosphoryla-
tion events, identifying and inhibiting cellular kinases which
phosphorylate transcription factors may represent one mech-
anism for inhibiting HCMV infection and/or replication. MAP
FIG. 5. Induction of CREB activity by US28, US27, UL33, and M33. Activation of CREB-luciferase was determined in transiently transfected
COS-7 cells (35,000 cells/well). Cells were cotransfected with a CREB-luciferase vector mixture (for details, see Materials and Methods) together
with increasing amounts of either vector DNA (white bars) as a control or US28 (A), US27 (B), UL33 (C), or M33 (D) DNA (black bars). Shown
are representative results from at least four independent experiments performed in quadruplicate. Data are means and standard errors of the
means. RLU were measured with a Packard TopCounter (5 s/well).
FIG. 6. Modulation of US28-induced inositol phosphate (PI) turnover and CREB activity by various CC chemokines and CX3CL. (A) Effects
of a 100 nM concentration of the chemokine domain of fractalkine/CX3CL1 (black bar) and RANTES/CCL5, MIP-1/CCL3, MIP-1/CCL4,
MCP-1/CCL2, MCP-3/CCL7, and vMIP-II/vCCL2 (grey bars) on the basal inositol phosphate turnover in COS-7 cells transfected with US28. The
asterisk indicates a statistically significant difference (P  0.05; unpaired t test) from the maximally obtained basal activity (control, white bar).
Experiments were carried out in duplicate (n  5). (B) Effect of RANTES/CCL5 (filled squares) or the chemokine domain of fractalkine/CX3CL
(open triangles) on the basal inositol phosphate turnover (filled circles) in COS-7 cells transiently transfected with the indicated amounts of US28
receptor DNA. The basal activity of 30 g of US27 is indicated by an open circle. One hundred percent corresponds to the maximally obtained
basal activity, and 0% corresponds to the background activity obtained with 30 g of empty expression vector pTEJ8. (C) COS-7 cells were
transiently transfected with increasing amounts of US28 receptor DNA and 50 ng of CREB-luciferase cDNA. The cells were exposed to either 100
nM RANTES/CCL5 (filled squares) or 100 nM fractalkine/CX3CL1 (open triangles) immediately following transfection. Basal constitutive activity
of US28 is represented by filled circles, and the activity in mock-transfected cells is represented by open circles. Shown are representative results
from at least four independent experiments performed in quadruplicate. Data in all three panels are means and standard errors of the means.
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kinases are examples of kinases which activate numerous tran-
scription factors, and some members of the MAP kinase family
are strongly activated following HCMV infection (33). In
mammalian cells, three general groups of MAP kinases have
been identified: ERK1/2, c-Jun N-terminal kinase, and p38 (for
a review, see reference 22). HCMV infection has been found to
activate both ERK1/2 and p38. ERK1/2 activation is observed
5 to 15 min following viral binding to the cell and at 4 to 8 h
postinfection following viral gene expression (33), whereas in-
creased p38 activity is detected at 8 h and maintained through
48 h postinfection (25). Hence, we next investigated the in-
volvement of the two main upstream MAP kinases involved in
CREB transcription via US28, UL33, and M33, i.e., ERK1/2
and p38 MAP kinases (36). The application of a 1 M con-
centration of the selective p38 inhibitor SB202190 decreased
CREB activation by US28 (Fig. 7A), M33 (Fig. 7B), and UL33
(Fig. 7C). This effect was specific, since 1 M SB202190 did not
impair the activation of NF-B by US28 (Fig. 7D) and M33
(Fig. 7E). Concentrations higher than 1 M SB202190 resulted
in nonspecific effects on both CREB and NF-B reporter plas-
mids alone (data not shown).We also showed that ERK1/2 is
not involved in the CREB activation process, since up to 30
M PD98059 had no effect on signaling by either US28 (Fig.
7A), M33 (Fig. 7B),or UL33 (Fig. 7C).
Since we could not totally eliminate the constitutive activa-
tion of CREB via p38 MAP kinase, we tested whether the
Gi-cAMP-PKA pathway could account for this residual effect
on CREB transcription. However, the application of 100 ng of
the selective Gi inhibitor PTX/ml did not affect CREB re-
porter activation by US28 (Fig. 7A), M33 (Fig. 7B), or UL33
(Fig. 7C). To date, the only report that Gi is involved in
intracellular signaling mediated by US28 is ligand-induced
Ca2 mobilization (6, 36, 41); however, neither ligand-medi-
ated smooth muscle cell migration (39) nor constitutive acti-
vation of NF-B (Fig. 7D) (10) was inhibited by PTX treat-
ment.
CMV-encoded receptors regulate NF-B transcription via
ERK1/2- and p38 MAP kinase-insensitive pathways. It is
known that NF-B activation can be regulated by multiple
pathways, including MAP kinases and inhibition of cAMP-
PKA (6, 14). However, our data suggest that the p38 MAP
kinase, ERK1/2-MAP kinase, and Gi-cAMP-PKA pathways
are not involved in US28 (Fig. 7D)- or M33 (Fig. 7E)-mediated
NF-B transcription, since none of the inhibitors used affected
the constitutive activation of NF-B. The slightly elevating
effect of 30 M PD98059 on NF-B–luciferase activity (Fig.
7D and E) likely was a nonspecific effect, since it was observed
even in mock-transfected cells (data not shown)
In the present study, we have identified and characterized
constitutive activity of the MCMV-encoded M33 receptor and
compared its signaling profiles to those of the HCMV-encoded
US28, US27, and UL33 (structural homologue of M33) recep-
FIG. 7. Effects of selected MAP kinase inhibitors and the Gi inhibitor PTX on receptor-mediated constitutive activation of CREB and NF-B.
COS-7 cells were transiently transfected with 40 ng of US28 (A and D), M33 (B and E), or UL33 (C) receptor DNA and 50 ng of either
CREB-luciferase (A, B, and C) or NF-B–luciferase (D and E) reporter DNA. Immediately following transfection, cells were incubated with a 1
M concentration of the selective p38 MAP kinase inhibitor SB202190 (grey bars) or a 30 M concentration of the ERK1/2-MAP kinase inhibitor
PD98059 (black bars). Likewise, transiently transfected COS-7 cells were treated with PTX (100 ng/ml) for 24 h (hatched bars). Data are shown
as percentages of the data for the control (100%), whereby the control represents the maximal constitutive activation of the respective reporter
in the presence of 40 ng of the respective receptor. The asterisk indicates a statistically significant difference (P  0.05; unpaired t test) from the
maximally obtained basal activity (control, white bar). Data are means and standard errors of the means for at least four independent experiments
performed in quadruplicate.
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tors. Our data suggest that constitutive activation of the host
cell transcription factors NF-B (Fig. 4) and CREB (Fig. 5) is
a more common feature in CMV-encoded 7TM receptors than
previously assumed. However, the levels of transcriptional ac-
tivation differ quite remarkably between the receptors. We
found that not only US28 but also UL33 and M33, besides
activating the PLC pathway in a ligand-independent manner
(Fig. 2), also upregulated the transcription factor CREB (Fig.
5). Our data further suggest that the primary route for this
constitutive CREB activation is through the p38 MAP kinase
pathway (Fig. 7). Interestingly, constitutive activation of tran-
scription factor NF-B was observed with only US28 from
HCMV and M33 from MCMV (Fig. 4A and D) and not with
the HCMV homologue of M33, UL33 (Fig. 4C). UL33 was
able to constitutively activate the Gq/PLC pathway (Fig. 2),
although apparently at a level insufficient for downstream
NF-B upregulation. A very recent study showed that R33, the
RCMV homologue of M33, like M33, is able to constitutively
activate NF-B transcription in a G-protein-dependent man-
ner (21). A possible structural explanation for the lack of
NF-B upregulation via UL33 could be that both M33 and
R33—but not UL33—possess an Asn (N) instead of an Asp
(D) in the otherwise well-conserved DRY motif located at the
boundary of transmembrane helix 3 and the second intracel-
lular loop of almost all G-protein-coupled receptors. This con-
served Asp-Arg-Tyr motif plays a pivotal role in G-protein
activation of 7TM receptors (35), and substitution of Asp with
Asn, as in M33 and R33, usually results in increased constitu-
tive activity (19, 28).
HCMV encodes two “extra” 7TM receptors, US27 and
US28, which are not found in the rodent CMVs (Fig. 1). It
could be argued either that US27 and US28 have been gained
by the human virus or that the two receptors have been lost by
the rodent virus. Whatever the case, it is interesting that, with
respect to signaling properties, M33 is more similar to US28
than to UL33, as both receptors are highly constitutively active
in the Gq/PLC signaling pathway, in CREB transcription, and
especially in NF-B transcription. Thus, it is likely that M33
plays a role similar to that of US28 at least in certain parts of
the viral life circle. However, US28 also has been suggested to
be involved in the sequestration of chemokines from the envi-
ronment of infected cells (7) and in cell-to-cell transfer of virus
(23, 26), based on the fact that US28 binds a broad variety of
CC chemokines besides the CX3C chemokine fractalkine/
CX3CL1. Such functions cannot at present be associated with
M33, as no chemokine ligands have yet been identified for this
receptor. Nevertheless, it should be noted that both M33 and
R33 have been shown to be essential in vivo for targeting of
CMV to or replication of CMV in the salivary glands of the
host (5, 13).
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